Mental Health

Investigators suggest that a checklist completed by physicians and family members of individuals with severe acute brain injury may improve management needs.

The formulation in 960 mg and 720 mg prefilled syringes delivers sustained plasma concentrations comparable to those demonstrated in studies with Abilify Maintena.

Pharmacists were asked about their levels of burnout, drivers and symptoms of this burnout, and what steps their workplaces had taken to improve the issue.

As psychedelic medicine comes further into cancer care, pharmacists will be an important part of the interdisciplinary team in screening and evaluating patients for suitability for psychedelic medicine.

Poor sleep efficiency may contribute to vascular dysfunction with increasing exposure to adverse childhood experiences.

Host Christina Madison, PharmD, BCACP, AAHIVP, sat down with Jeffrey Bratberg, PharmD, FAPhA, a clinical professor in the college of pharmacy at the University of Rhode Island

Pharmacists must be involved in managing adverse effects and drug-drug interactions as psychedelic medicines collide with traditional psychiatric treatments.

Some classes and curricula can contribute to preexisting stigmas about drugs and treatments for mental health.

Based on the study results, investigators concluded that there is justification for a randomized clinical trial.

The Aquilino Cancer Center established the Bill Richards Center for Healing inside the same building, so patients with cancer can receive psychedelic-assisted therapy in the same location as their cancer care.

The risk is particularly high in the first 2 years after an HIV diagnosis.

To build a brighter, healthier, and more equitable future for all US citizens, there is an indisputable need to decriminalize psychedelic medicines.

Discussions are led by a variety of experienced preceptors to provide insight, strategies, and resources for pharmacy residents.

Pharmacists are cited as one of the most stressed professions and a creative habit can help to improve focus, enhance productivity, and reduce stress.

Investigators suggest that sleep interventions may help to reduce the risk of self-harm in female adolescents with depression and anxiety.

In addition to improving working conditions for current employees, burnout must be addressed in order to recruit and retain new employees and alleviate understaffing.

This month, we spoke with expert Adi Zuloff-Shani, PhD, CEO of Clearmind Medicine.

New access laws allow pharmacists to establish standing orders with specific physicians or follow blanket, statewide protocols.

The COVID-19 pandemic marginally affected the negative mental health of women more than men, according to a new study.

Emotional support greatly improved symptoms of psychological distress from the pandemic among pregnant women.

Perceived stress and cognitive performance are independently associated. Stress can also increase the risk of worsening cognition.

The COVID-19 pandemic was associated with an increase in rural-urban telemedicine divide across the Veteran Affairs health care system.

Persistently pursuing valued goals and adjusting those goals in response to setbacks or obstacles may help explain how some individuals with chronic pain maintain their mental wellbeing.

Pharmacy programs are implementing new practices into their curriculum and research is being focused on mental health care.

The study clarifies why serotonin-based therapeutics, such as selective serotonin reuptake inhibitors, do not promote neuroplasticity in the same ways as psychedelics and other psychoplastogenic therapeutics.

Substance use disorder is a significant social, economic, and public health crisis, with far too few individuals receiving the treatment they need, particularly among communities of color.

Current treatment options for depression lead to discontinuation because they are slower to work and have worse adverse event profiles.

Managing understaffing and increasingly demanding workflows is an ongoing challenge in pharmacy.

Austedo XR will be available in 3 extended-release tablet strengths, which provides an updated regimen that may result in a lower pill count for patients.

Those seeking abortion were found to have triple the risk of a psychiatric disorder compared to the general population.